We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion.
- Authors
Fung, James; Lai, Ching-Lung; Tanaka, Yasuhito; Mizokami, Masashi; Yuen, John; Wong, Danny Ka-Ho; Yuen, Man-Fung
- Abstract
The aim of this study was to compare the virological and biochemical relapse rates in Asian chronic hepatitis B patients with lamivudine-induced hepatitis B e antigen (HBeAg) seroconversion, between those who stopped therapy after HBeAg seroconversion and those who continued to receive lamivudine.
- Publication
The American journal of gastroenterology, 2009, Vol 104, Issue 8, p1940
- ISSN
1572-0241
- Publication type
Journal Article
- DOI
10.1038/ajg.2009.200